↓ Skip to main content

Dove Medical Press

Curcumin induces apoptosis and protective autophagy in castration-resistant prostate cancer cells through iron chelation

Overview of attention for article published in Drug Design, Development and Therapy, February 2017
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (71st percentile)
  • Good Attention Score compared to outputs of the same age and source (71st percentile)

Mentioned by

twitter
5 X users
facebook
2 Facebook pages
googleplus
1 Google+ user

Citations

dimensions_citation
86 Dimensions

Readers on

mendeley
81 Mendeley
Title
Curcumin induces apoptosis and protective autophagy in castration-resistant prostate cancer cells through iron chelation
Published in
Drug Design, Development and Therapy, February 2017
DOI 10.2147/dddt.s126964
Pubmed ID
Authors

Chunguang Yang, Xueyou Ma, Zhihua Wang, Xing Zeng, Zhiquan Hu, Zhangqun Ye, Guanxin Shen

Abstract

Curcumin induces apoptosis and autophagy in different cancer cells. Moreover, chemical and biological experiments have evidenced that curcumin is a biologically active iron chelator and induces cytotoxicity through iron chelation. We thus hypothesized that curcumin may induce apoptosis and autophagy in castration-resistant prostate cancer (CRPC) cells through its iron-chelating properties. CRPC cells were loaded with curcumin alone or in combination with ferric ammonium citrate (FAC). Cytotoxicity was measured by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. Apoptosis was assessed by flow cytometry, terminal deoxynucleotidyl transferase nick end labeling (TUNEL) assay and caspase activity. Autophagy status was analyzed by the detection of autophagosomes and light chain 3-II (LC3-II) using transmission electron microscopy and Western blot. Iron-binding activity of curcumin was assessed by spectrophotometry and MTT assay. The expression levels of transferrin receptor 1 (TfR1) and iron regulatory protein 1 (IRP1) were examined by Western blot. Curcumin induced apoptosis and autophagy in CRPC cells. Combining curcumin with autophagy inhibitors (3-methyladenine [3-MA]) synergized the apoptotic effect of curcumin. Moreover, curcumin bound to FAC at a ratio of ~1:1, as assessed by spectrophotometry and MTT assay. Apoptosis and autophagy induced by curcumin were counteracted by equal amounts of FAC. At apoptosis- and autophagy-inducing concentrations, curcumin enhanced the expression levels of TfR1 and IRP1, indicative of iron deprivation induced by curcumin. Together, our results indicate that curcumin induces apoptosis and protective autophagy in CRPC cells, which are at least partially dependent on its iron-chelating properties.

X Demographics

X Demographics

The data shown below were collected from the profiles of 5 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 81 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 81 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 14 17%
Student > Bachelor 11 14%
Student > Ph. D. Student 10 12%
Researcher 8 10%
Other 5 6%
Other 14 17%
Unknown 19 23%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 26 32%
Pharmacology, Toxicology and Pharmaceutical Science 7 9%
Nursing and Health Professions 7 9%
Medicine and Dentistry 5 6%
Agricultural and Biological Sciences 4 5%
Other 10 12%
Unknown 22 27%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 5. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 15 May 2018.
All research outputs
#6,823,235
of 25,584,565 outputs
Outputs from Drug Design, Development and Therapy
#432
of 2,254 outputs
Outputs of similar age
#118,363
of 426,137 outputs
Outputs of similar age from Drug Design, Development and Therapy
#14
of 45 outputs
Altmetric has tracked 25,584,565 research outputs across all sources so far. This one has received more attention than most of these and is in the 72nd percentile.
So far Altmetric has tracked 2,254 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.3. This one has done well, scoring higher than 80% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 426,137 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 71% of its contemporaries.
We're also able to compare this research output to 45 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 71% of its contemporaries.